Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Inhibition of telomerase is proposed to limit the growth of cancer cells by triggering telomere shortening and cell death. Telomere maintenance by telomerase is sufficient, in some cell types, to allow immortal growth. Telomerase has been shown to cooperate with oncogenes in transforming cultured primary human cells into neoplastic cells, suggesting that telomerase activation contributes to malignant transformation. Moreover, telomerase inhibition in human tumour cell lines using dominant-negative versions of TERT leads to telomere shortening and cell death. These findings have led to the proposition that telomerase inhibition may result in cessation of tumour growth. The absence of telomerase from most normal cells supports the potential efficacy of anti-telomerase drugs for tumour therapy, as its inhibition is unlikely to have toxic effects. Mice deficient for Terc RNA (encoding telomerase) lack telomerase activity, and constitute a model for evaluating the role of telomerase and telomeres in tumourigenesis. Late-generation Terc-/- mice show defects in proliferative tissues and a moderate increase in the incidence of spontaneous tumours in highly proliferative cell types (lymphomas, teratocarcinomas). The appearance of these tumours is thought to be a consequence of chromosomal instability in these mice. These observations have challenged the expected effectiveness of anti-telomerase-based cancer therapies. Different cell types may nonetheless vary in their sensitivity to t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“findings consistent with previous studies establishing that telomere dysfunction acts as a tumor suppressor when p53 function is intact (7, 8, 30, 48).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [48]
In the citing paper
“Loss of telomerase activity in mice has been shown to suppress tumorigenesis in various tumour models [13][14][15][16]”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [13]
In the citing paper
“In a transgenic breast cancer model driven by Polyoma Middle T antigen, telomere dysfunction significantly impaired not only tumor latency and penetrance but also reduced metastatic potential (90).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [90]
In the citing paper
“A similar finding was observed in a skin carcinogenesis model, in which late generation mTerc−/− mice produced 20-fold fewer skin tumors upon chemical carcinogenesis treatment of the skin compared to wild-type controls with long telomeres50.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [50]
Citations
Cites
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Self-citationTelomere elongation in immortal human cells without detectable telomerase activity
Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S., & Reddel, R. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00098.x · Cited by 1,279
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
Self-citationKiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
Inhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979 · cited 1×
“The appearance of these tumours is thought to be a consequence of chromosomal instability in these mic”
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
Quintanilla, M., Brown, K., Ramsden, M., & Balmain, A. (1986) · Nature · doi:10.1038/322078a0 · Cited by 859 · cited 1×
“H-RAS activation and telomerase upregulation are reported to occur in most DMBA-initiated papilloma”
Background
Research works printed but not linked: 1
- Hennings, H. Primary culture of keratinocytes from newborn mouse epidermis in medium with lowered levels of Ca2+. in Keratinocyte Methods (eds Leigh, I.M. & Watt, F.M.) 21–23 (Cambridge University Press, New York, 1994).
Cited by
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
Telomeres and human disease: ageing, cancer and beyond
Blasco, M. A. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1656 · Cited by 1,434
Self-citationEpidermal Stem Cells of the Skin
Blanpain, C., & Fuchs, E. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104357 · Cited by 849
“Conversely, mice deficient for TERC, another key component of telomerase, are resistant to skin chemical carcinogenesis (Gonzalez-Suarez et al. 2000).”
BackgroundTelomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Telomere length, stem cells and aging
Blasco, M. A. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.38 · Cited by 747
Self-citationTelomerase maintains telomere structure in normal human cells
Kenichi, M., Yu, E. Y., Shilagardi, K., Ben‐Porath, I., Currier, J. L., Metz, G. B., Brooks, M. W., Kaneko, S., Seishi, M., DeCaprio, J. A., et al. (2006) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 738
Connecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0977com · Cited by 527
“To directly assess which cell type in the cirrhotic liver shows telomere shortening, quantitative fluorescence in situ hybridization (Q-FISH) on interphase nuclei was performed on frozen sections of cirrhotic livers using a telomere-specific PNA probe (16, 17).”
MethodInfluentialSelf-citationTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527
Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Martínez, P., & Blasco, M. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3025 · Cited by 468
Self-citationHallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
Telomere Dysfunction: A Potential Cancer Predisposition Factor
Wu, X., Amos, C. I., Zhu, Y., Zhao, H., Grossman, B. H., Shay, J. W., Luo, S., Hong, W. K., & Spitz, M. R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg011 · Cited by 494
Different telomere damage signaling pathways in human and mouse cells
Smogorzewska, A., & de Lange, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf433 · Cited by 482
“Indeed, short telomeres appear to suppress the formation of DMBA/TPA-induced [7,12-dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA)] skin tumors (Gonzalez-Suarez et al., 2000) and intestinal carcinomas in the ApcMin mouse (Rudolph et al.”
BackgroundTelomeres, stem cells, senescence, and cancer
Sharpless, N. E., & DePinho, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20761 · Cited by 473
Delayed ageing through damage protection by the Arf/p53 pathway
Matheu, A., Maraver, A., Klatt, P., Flores, I., Garcia-Cao, I., Borras, C., Flores, J. M., Viña, J., Blasco, M. A., & Serrano, M. (2007) · Nature · doi:10.1038/nature05949 · Cited by 466
Self-citationInside and out: the activities of senescence in cancer
Pérez-Mancera, P. A., Young, A. R. J., & Narita, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3773 · Cited by 462
Effects of Telomerase and Telomere Length on Epidermal Stem Cell Behavior
Flores, I., Cayuela, M. L., & Blasco, M. A. (2005) · Science · doi:10.1126/science.1115025 · Cited by 448
Self-citationTelomerase modulates expression of growth-controlling genes and enhances cell proliferation
Smith, L. L., Coller, H. A., & Roberts, J. M. (2003) · Nature Cell Biology · doi:10.1038/ncb985 · Cited by 438
Putting the stress on senescence
Serrano, M., & Blasco, M. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00278-7 · Cited by 413
Self-citationTelomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411
Cellular senescence, cancer and aging: the telomere connection
Campisi, J., Kim, S.-H., Lim, C.-S., & Rubio, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00160-7 · Cited by 400
González‐Suárez, E., Samper, E., Ramírez, A., Flores, J. M., Martín‐Caballero, J., Jorcano, J. L., & Blasco, M. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2619 · Cited by 372
Self-citationOncogene-Induced Cell Senescence — Halting on the Road to Cancer
Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371
Natural and pharmacological regulation of telomerase
Mergny, J.-L. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.839 · Cited by 352
“Results obtained with mice lacking a functional telomerase enzyme and in successive generations of mice doubly inactivated for telomerase and INK4a clearly show that telomere dysfunction impairs tumour development (24,25).”
BackgroundThe longest telomeres: a general signature of adult stem cell compartments
Flores, I., Canela, A., Vera, E., Tejera, A., Cotsarelis, G., & Blasco, M. A. (2008) · Genes & Development · doi:10.1101/gad.451008 · Cited by 352
Self-citationMechanisms of cellular senescence in human and mouse cells.
Itahana, K., Campisi, J., & Dimri, G. P. (2004) · Biogerontology · doi:10.1023/b:bgen.0000017682.96395.10 · Cited by 338
“The fifth generation mTR−/− mice are resistant to carcinogen induced skin tumors in a p53 dependent manner (Gonzalez-Suarez et al. 2000).”
BackgroundNon-melanoma skin cancer: what drives tumor development and progression?
Boukamp, P. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi123 · Cited by 338
Telomerase: A target for cancer therapeutics
Shay, J. W., & Wright, W. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00159-9 · Cited by 339
Constitutive telomerase expression promotes mammary carcinomas in aging mice
Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., Greenberg, R. A., Castrillon, D. H., Horner, J. W., Weiler, S. R., Carrasco, R. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112515399 · Cited by 317
Short Telomeres Limit Tumor Progression In Vivo by Inducing Senescence
Feldser, D. M., & Greider, C. W. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.026 · Cited by 314
“telomere response significantly limits tumor formation (Gonzalez-Suarez et al., 2000; Greenberg et al., 1999; Qi et al., 2003, 2005; Rudolph et al., 2001; Wong et al., 2003).”
InfluentialLeri, A., Franco, S., Zacheo, A., Barlucchi, L., Chimenti, S., Limana, F., Nadal‐Ginard, B., Kajstura, J., Anversa, P., & Blasco, M. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg013 · Cited by 313
Self-citationMathon, N. F., & Lloyd, A. C. (2001) · Nature Reviews Cancer · doi:10.1038/35106045 · Cited by 308
Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
Hu, J., Hwang, S. S., Liesa, M., Gan, B., Sahin, E., Jaskelioff, M., Ding, Z., Ying, H., Boutin, A. T., Zhang, H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.028 · Cited by 296
Cellular senescence in vivo: a barrier to tumorigenesis
Prieur, A., & Peeper, D. S. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.007 · Cited by 260
Samper, E., Flores, J. M., & Blasco, M. A. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve174 · Cited by 263
“In support of this, mice that lack telomerase and have critically short telomeres display severe proliferative defects and, in the presence of wild-type p53, they are less susceptible to developing tumors (Chin et al., 1999; Greenberg et al., 1999; González-Suárez et al., 2000).”
BackgroundSelf-citationTelomere-driven diseases and telomere-targeting therapies
Martínez, P., & Blasco, M. A. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201610111 · Cited by 257
“…the K-Ras+/G12D lung tumorigenesis mouse model, showed antitumorigenic activity only after several mouse generations in the absence of telomerase when telomeres reached a critically short length (Chin et al., 1999; Greenberg et al., 1999; González-Suárez et al., 2000; Perera et al., 2008).”
BackgroundSelf-citationTelomerase at the intersection of cancer and aging
Bernardes de Jesus, B., & Blasco, M. A. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.06.007 · Cited by 227
Self-citationMice with Pulmonary Fibrosis Driven by Telomere Dysfunction
Povedano, J. M., Martinez, P., Flores, J. M., Mulero, F., & Blasco, M. A. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.028 · Cited by 225
“Telomere Analysis qFISHdetermination onparaffin-embedded tissuesections was performed as described previously (Gonza´lez-Sua´rez et al., 2000).”
MethodSelf-citationGowan, S. M., Heald, R., Stevens, M. F. G., & Kelland, L. R. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12507-2 · Cited by 230
“Telomerase activation has been shown to represent a key step in human epithelial tumor oncogenesis (Hahn et al., 1999a; Gonzalez-Suarez et al., 2000), and studies of telomerase-negative knockout mice have revealed its role in maintaining high renewal organs (Lee et al., 1998).”
Telomeres, aging and cancer: In search of a happy ending
Kim, S.-H., Kaminker, P., & Campisi, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205077 · Cited by 230
“Moreover, late generation telomerase-de®cient mice can be resistant to cancer in some tissues and some genetic backgrounds (Gonzalez-Suarez et al., 2000; Greenberg et al., 1999).”
BackgroundMuñoz, P., Blanco, R., Flores, J. M., & Blasco, M. A. (2005) · Nature Genetics · doi:10.1038/ng1633 · Cited by 226
Self-citationDing, Z., Wu, C.-J., Jaskelioff, M., Ivanova, E., Kost-Alimova, M., Protopopov, A., Chu, G. C., Wang, G., Lu, X., Labrot, E. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.039 · Cited by 220
“These observations reinforced the established role of telomere dysfunction in facilitating cancer initiation yet constraining full malignant progression (Rudolph et al., 2001; González-Suárez et al., 2000; Chin et al., 1999), whereas telomerase reactivation enabled rapidly progressive disease.”
Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres
Espejel, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2207 · Cited by 217
Self-citationLiu, L., Trimarchi, J. R., Navarro, P., Blasco, M. A., & Keefe, D. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303553200 · Cited by 216
Self-citationTelomere Length Assessment in Human Archival Tissues
Meeker, A. K., Gage, W. R., Hicks, J. L., Simon, I., Coffman, J. R., Platz, E. A., March, G. E., & De Marzo, A. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62553-9 · Cited by 209
A ‘higher order’ of telomere regulation: telomere heterochromatin and telomeric RNAs
Schoeftner, S., & Blasco, M. A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.197 · Cited by 213
“…in stem cell dysfunction, premature loss of tissue regeneration, and reduced life span, as shown in the context of telomerase-deficient mice (Blasco et al, 1997; Herrera et al, 1999; Rudolph et al, 1999; Gonzalez-Suarez et al, 2000; Collins and Mitchell, 2002; Blasco, 2005; Garcia-Cao et al, 2006).”
BackgroundSelf-citationCosme‐Blanco, W., Shen, M., Lazar, A. J. F., Pathak, S., Lozano, G., Multani, A. S., & Chang, S. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7400937 · Cited by 205
“Senescence does not suppress DMBA-induced skin cancer The classic chemically induced skin carcinogenesis model associated with Ras-activating mutations shows that dysfunctional telomeres potently suppress skin tumorigenesis in the presence of wild-type p53 (Fig 5A; Gonzalez-Suarez et al, 2000).”
BackgroundMethodHarley, C. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205076 · Cited by 150
“…there now exists compelling cell and animal data for the potential of killing telomerasepositive cancer cells through telomerase inhibition (Gonzalez-Suarez et al., 2000, through therapeutic telomerase vaccines (Minev et al., 2000; Nair et al., 2000; Vonderheide et al., 1999), and through…”
BackgroundTelomere shortening in human diseases
Kong, C. M., Lee, X. W., & Wang, X. (2013) · The FEBS Journal · doi:10.1111/febs.12326 · Cited by 194
Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer
Artandi, S. E., & Attardi, L. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.211 · Cited by 191
Telomeres in cancer and ageing
Donate, L. E., & Blasco, M. A. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2010.0291 · Cited by 190
Self-citationBajaj, S., Asati, V., Singh, J., & Roy, P. P. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.051 · Cited by 187
Assessing cell and organ senescence biomarkers
de Jesus, B. B., & Blasco, M. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247866 · Cited by 187
Self-citationTelomere-related Genome Instability in Cancer
DE LANGE, T. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.032 · Cited by 182
“When such mice are challenged with DMBA/TPA to promote skin tumors, short telomeres have a tumor-suppressive effect (Gonzalez-Suarez et al. 2000).”
BackgroundChang, S., Khoo, C. M., Naylor, M. L., Maser, R. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1029903 · Cited by 183
“In cancer-prone Ink4a/Arf mutant or Apc mice and in a carcinogeninduced skin cancer model, telomere dysfunction results in a marked reduction in tumor incidence and prolonged survival (Greenberg et al. 1999; Gonzalez-Suarez et al. 2000; Rudolph et al. 2000).”
BackgroundBlasco, M. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc862 · Cited by 175
Self-citationBehaviour of Telomere and Telomerase during Aging and Regeneration in Zebrafish
Anchelin, M., Murcia, L., Alcaraz-Pérez, F., García-Navarro, E. M., & Cayuela, M. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016955 · Cited by 168
“. In mammals, telomerase is expressed in germ cells and in the stem cell compartment of several adult tissues. It has been proposed that telomerase may be important for tissue regeneration after injury. In fact, phenotypes associated with premature loss of tissue regeneration, including the skin (hair loss, hair greyi…”
BackgroundRole of shelterin in cancer and aging
Martínez, P., & Blasco, M. A. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00596.x · Cited by 136
“Mice that lack telomerase activity are resistant to cancer (Greenberg et al., 1999; Gonzalez-Suarez et al., 2000; Feldser & Greider, 2007), with the exception of p53-deficient, MSH2-deficient and TRF2-overexpressing genetic backgrounds (Table 1) (Chin et al.”
BackgroundSelf-citationThe Role of Telomere Biology in Cancer
Xu, L., Li, S., & Stohr, B. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164030 · Cited by 160
Satyanarayana, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg367 · Cited by 159
“To test this hypothesis, telomere length was analyzed at the single-cell level using quantitative ̄uorescence in situ hybridization (qFISH) (Gonzalez-Suarez et al., 2000; Poon and Landsdorp, 2001) in combination with BrdU staining (Figure 2A±C).”
MethodSelf-citationTransformation of normal human cells in the absence of telomerase activation
Seger, Y. R., Garcı́a-Cao, M., Piccinin, S., Cunsolo, C. L., Doglioni, C., Blasco, M. A., Hannon, G. J., & Maestro, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00183-6 · Cited by 159
“…abnormalities are a characteristic outcome of telo- validity of our transformation model in several additional human primary fibroblasts, including HSF43, WI-38, Detroit 551, andmere depletion and are similar to those seen in the karyotypes of Terc / mice (Blasco et al., 1997b; Nanda et al., 1995).”
MethodResultSelf-citationFarazi, P. A., Glickman, J. N., Jiang, S., Yu, A., Rudolph, K. L., & DePinho, R. A. (2003) · PubMed · Cited by 201
Telomeres and telomerase: A dual role in hepatocarcinogenesis
Satyanarayana, A., Manns, M. P., & Rudolph, L. K. (2004) · Hepatology · doi:10.1002/hep.20308 · Cited by 158
Capozza, F., Williams, T. M., Schubert, W., McClain, S. A., Bouzahzah, B., Sotgia, F., & Lisanti, M. P. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64335-0 · Cited by 179
Telomerase, senescence and ageing
Shawi, M., & Autexier, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.007 · Cited by 170
Djojosubroto, M. W., Chin, A. C., Go, N., Schaetzlein, S., Manns, M. P., Gryaznov, S., Harley, C. B., & Rudolph, L. K. (2005) · Hepatology · doi:10.1002/hep.20822 · Cited by 151
Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging
Blasco, M. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600598 · Cited by 164
“…activity but still have long telomeres, were shown to have less skin tumors than wild-type mice following skin chemical carcinogenesis, indicating a negative impact of telomerase deficiency on tumor growth even in the presence of sufficiently long telomeres (González-Suárez et al, 2000).”
BackgroundSelf-citationTelomeres and Telomerase in Aging, Regeneration and Cancer
Djojosubroto, M. W., Choi, Y. S., Lee, H., & Rudolph, K. L. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13723-x · Cited by 172
Povedano, J. M., Martinez, P., Serrano, R., Tejera, Á., Gómez-López, G., Bobadilla, M., Flores, J. M., Bosch, F., & Blasco, M. A. (2018) · eLife · doi:10.7554/elife.31299 · Cited by 139
“Q-FISH determination on paraffin-embedded tissue sections was performed as described previously (González-Suárez et al., 2000).”
MethodSelf-citationRole of Telomeres and Telomerase in the Pathogenesis of Human Cancer
Hahn, W. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.018 · Cited by 156
“mice were treated with carcinogens known to induce a predictable progression of skin cancers.(123) These observations in both”
BackgroundMultistep skin cancer in mice as a model to study the evolution of cancer cells
Kemp, C. J. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.003 · Cited by 159
Telomere dysfunction, genome instability and cancer
Cheung, A. (2008) · Frontiers in Bioscience · doi:10.2741/2825 · Cited by 139
“Telomere dysfunction-mediated chromosomal instability in telomerase deficient mice also suppresses carcinogeninduced skin carcinogenesis in Terc mice (138).”
BackgroundRole of telomere dysfunction in cardiac failure in Duchenne muscular dystrophy
Mourkioti, F., Kustan, J., Kraft, P., Day, J. W., Zhao, M.-M., Kost-Alimova, M., Protopopov, A., DePinho, R. A., Bernstein, D., Meeker, A. K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2790 · Cited by 136
Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis
Blanco, R., Muñoz, P., Flores, J. M., Klatt, P., & Blasco, M. A. (2007) · Genes & Development · doi:10.1101/gad.406207 · Cited by 135
“In particular, we studied preneoplastic and neoplastic lesions in the skin, the esophagus, and the nonglandular stomach, where the K5 promoter is expressed (Murillas et al. 1995; González-Suárez et al. 2001, 2002).”
BackgroundInfluentialSelf-citationTRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
Biroccio, A., Cherfils‐Vicini, J., Augereau, A., Pinte, S., Bauwens, S., Ye, J., Simonet, T., Horard, B., Jamet, K., Cervera, L., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2774 · Cited by 149
Role of genomic instability in arsenic-induced carcinogenicity. A review
Bhattacharjee, P., Banerjee, M., & Giri, A. K. (2013) · Environment International · doi:10.1016/j.envint.2012.12.004 · Cited by 150
“are known to promote carcinogenesis in p53 mutant backgrounds (Chin et al., 1999; González-Suárez et al., 2000; Oulton and Harrington, 2000).”
BackgroundCancer and aging: the importance of telomeres in genome maintenance
Rodier, F., Kim, S.-H., Nijjar, T., Yaswen, P., & Campisi, J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.012 · Cited by 132
“Moreover, telomere stabilization may, at least under some circumstances, prevent or delay the development of aging phenotypes in certain tissues [19-26].”
BackgroundFunctional interaction between DNA‐PKcs and telomerase in telomere length maintenance
Espejel, S., Franco, S., Sgura, A., Gae, D., Bailey, S. M., Taccioli, G. E., & Blasco, M. A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf593 · Cited by 149
Self-citationMolecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging
Zhang, H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20919 · Cited by 128
“Laboratory mice Mus musculus have unusually long telomeres and their somatic cells express high level of telomerase (Kipling and Cooke, 1990; Prowse and Greider, 1995; Greenberg et al., 1998).”
BackgroundRole of telomeres and telomerase in genomic instability, senescence and cancer
Deng, Y., & Chang, S. S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700673 · Cited by 129
“A similar finding was observed in a skin carcinogenesis model, in which telomerase null mice with dysfunctional telomeres produced significantly fewer advanced skin tumors after chemical carcinogenesis treatment of the skin compared to wild-type control animals with long telomeres.(18) Increased p53 staining was readi…”
ResultCairney, C. J., & Keith, W. N. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.025 · Cited by 140
Evolving views of telomerase and cancer
Blasco, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00085-0 · Cited by 123
Self-citationHeald, R. A., Modi, C., Cookson, J. C., Hutchinson, I. S., Laughton, C. A., Gowan, S. M., Kèlland, L. R., & Stevens, M. F. G. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm011015q · Cited by 129
Telomerase and the search for the end of cancer
Mocellin, S., Pooley, K. A., & Nitti, D. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.11.006 · Cited by 131
Farazi, P. A., Glickman, J., Horner, J., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4608 · Cited by 119
Premature aging in telomerase-deficient zebrafish
Anchelin, M., Alcaraz-Pérez, F., Martínez, C. M., Bernabé-García, M., Mulero, V., & Cayuela, M. L. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011635 · Cited by 114
“Notably, telomere attrition triggered p53-dependent apoptosis in early embryonic stages and p53 deficiency rescued the adverse effects of telomere loss, as reported in the mouse (González-Suárez et al., 2000; Leri et al., 2003).”
Mitochondria, Telomeres and Telomerase Subunits
Zheng, Q., Huang, J., & Wang, G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00274 · Cited by 130
Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice
González-Suárez, E., Geserick, C., Flores, J. M., & Blasco, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208413 · Cited by 109
Self-citationBeyond average: potential for measurement of short telomeres
Vera, E., & Blasco, M. A. (2012) · Aging · doi:10.18632/aging.100462 · Cited by 109
“While the telomere Q-FISH method on metaphases can only be performed on actively proliferating cells as it requires cells at the metaphase stage of the cell cycle, the more recent development of telomere Q-FISH protocols for cells in interphase [37] allow measurement of telomere length in tissue sections or other nonp…”
MethodSelf-citationTelomeres in aging and disease: lessons from zebrafish
Carneiro, M. C., de Castro, I. P., & Ferreira, M. G. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.025130 · Cited by 114
Mammalian telomeres and telomerase: why they matter for cancer and aging
Blasco, M. A. (2003) · European Journal of Cell Biology · doi:10.1078/0171-9335-00335 · Cited by 122
Self-citationTelomerase activity is required for bleomycin-induced pulmonary fibrosis in mice
Liu, T., Chung, M. J., Ullenbruch, M., Yu, H., Jin, H., Hu, B., Choi, Y. Y., Ishikawa, F., & Phan, S. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32369 · Cited by 104
Gramatges, M. M., Telli, M. L., Balise, R. R., & Ford, J. M. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0896 · Cited by 112
Increased p53 activity does not accelerate telomere‐driven ageing
García‐Cao, I., García‐Cao, M., Tomás‐Loba, A., Martin‐Caballero, J., Flores, J. M., Klatt, P., Blasco, M. A., & Serrano, M. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400667 · Cited by 102
“The tumour suppressor p53 is an important sensor of dysfunctional telomeres (Chin et al, 1999; Gonzalez-Suarez et al, 2000; Smogorzewska & de Lange, 2002; Leri et al, 2003; Sharpless & DePinho, 2004).”
BackgroundSelf-citationLiu, L., Blasco, M. A., & Keefe, D. L. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf055 · Cited by 102
“TR–/– mice lack telomerase activity and show progressive telomere shortening with increasing mouse generations, eventually resulting in telomere-exhausted chromosomes and chromosomal end-to-end fusions (Blasco et al., 1997; Lee et al., 1998; Herrera et al., 1999a,b; Rudolph et al., 1999; Gonzalez-Suarez et al., 2000).”
Self-citationExpression of POT1 is Associated with Tumor Stage and Telomere Length in Gastric Carcinoma
Kondo, T., Oue, N., Yoshida, K., Mitani, Y., Naka, K., Nakayama, H., & Yasui, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1196 · Cited by 118
Telomere instability and cancer
Londoño‐Vallejo, A. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.009 · Cited by 104
Telomeres and telomerase in cancer stem cells
Ju, Z., & Rudolph, K. L. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.040 · Cited by 100
Many ways to telomere dysfunction: in vivo studies using mouse models
Goytisolo, F. A., & Blasco, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205085 · Cited by 105
“This tumor suppressor phenotype coincides with p53 upregulation in Terc7/7 papillomas, that may be sensing short telomeres as damagedDNAand contributing to cessation of growth (Gonzalez-Suarez et al., 2000).”
BackgroundSelf-citationGonzález-Suárez, E., Flores, J. M., & Blasco, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7291-7301.2002 · Cited by 95
“The negative impact of telomerase deficiency and telomere shortening on tumor development in the context of an organism has been extensively addressed in the past by using the telomerase-deficient mouse model (3, 5, 8, 11, 24, 25).”
BackgroundMethodSelf-citation
Metadata
- Authors
- González-Suárez, E., Samper, E., Flores, J. M., & Blasco, M. A.
- Affiliations
- Centro Nacional de Biotecnología (ES)
- Universidad Complutense de Madrid (ES)
- ORCID
- Flores, Juana M.
- Venue
- Nature Genetics
- Published
- 2000-09
- Volume
- 26
- Issue
- 1
- Pages
- 114-117
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1573467049
- Cited by
- 347
- References
- 29
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 11 · 2019: 9 · 2018: 2 · 2017: 5 · 2016: 11 · 2015: 7 · 2014: 7 · 2013: 21 · 2012: 14
- FWCI
- 17.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- telomerase, telomere shortening, skin carcinogenesis, chromosomal instability, lymphoma, teratocarcinoma, epithelial tumors, telomere maintenance, malignant transformation
- MeSH terms
- Animals, Carcinogens, Flow Cytometry, Immunity, Innate, Immunohistochemistry, Mice, Inbred C57BL, Mice, Mutant Strains, Papilloma, Skin, Skin Neoplasms, Tetradecanoylphorbol Acetate, Time Factors, 9,10-Dimethyl-1,2-benzanthracene, Keratinocytes, Tumor Suppressor Protein p53, Proto-Oncogene Proteins p21(ras), Telomere, In Situ Hybridization, Fluorescence, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.